VentriPoint Diagnostics Ltd V.VPT

VMS+ tech. and its unique contributions to advancing cardiac

[jopatclo]

Bart HendriksBart Hendriks• Following• FollowingEntrepreneurial CEO and Strategic Advisor in the field of MedTech, with expertise in pioneering clinical AI applications and cutting-edge technology.Entrepreneurial CEO and Strategic Advisor in the field of MedTech, with expertise in pioneering clinical AI applications and cutting-edge technology.

9m • 9 minutes ago

 

In this article, we explore the transformative potential of Artificial Intelligence (AI) in clinical trials, highlighting its current challenges in daily clinical practice and showcasing how AI is revolutionizing the field of cardiology. We will delve into the specific advantages AI offers in improving efficiency, accuracy, and outcomes in clinical trials, with a special focus on Ventripoint's VMS+ technology and its unique contributions to advancing cardiac research.

Embracing AI in Clinical Trials: The Future of Medical Research

Bart Hendriks on LinkedIn • 4 min read

In recent years, Artificial Intelligence (AI) has made significant strides in various industries, including healthcare. However, while AI's integratio

[jopatclo]

Good comment on Linkedin  Andrew Bonner, MBAAndrew Bonner, MBA • 3rd+ • 3rd+Dad, Sales LeaderDad, Sales Leader2d • 2 days ago Follow   Sharing an article on how AI may impact the healthcare industry specifically for loved ones with chronic heart disease. Ventripoint Diagnostics provides faster, less expensive and